SMTL ID : 3ui7.1 (1 other biounit)

Discovery of orally active pyrazoloquinoline as a potent PDE10 inhibitor for the management of schizophrenia

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.28 Å

Oligo State

monomer

Ligands

1 x C1L: 6-methoxy-3,8-dimethyl-4-(morpholin-4-ylmethyl)-1H-pyrazolo[3,4-b]quinoline(Non-covalent)

C1L.1: 11 residues within 4Å: Chain A: Y.87, H.88, L.238, S.240, V.241, I.255, Y.256, F.259, M.276, Q.289, F.292 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.238, A:F.292, A:F.292 Hydrogen bonds: A:Q.289, A:Q.289 Water bridges: A:Y.293 pi-Stacking: A:F.259, A:F.292

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 4 residues within 4Å: Chain A: D.127, E.155, H.158 Ligands: ZN.3 5 PLIP interactions: 1 interactions with chain A, 4 Ligand-Water interactions Metal complexes: A:D.127, H2O.1, H2O.1, H2O.1, H2O.1

1 x ZN: ZINC ION(Non-covalent)

ZN.3: 5 residues within 4Å: Chain A: H.92, H.126, D.127, D.237 Ligands: MG.2 6 PLIP interactions: 4 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:H.92, A:H.126, A:D.127, A:D.237, H2O.1, H2O.3

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yang, S.W. et al., Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophrenia. Bioorg.Med.Chem.Lett. (2012)

Release Date

2011-12-21

Peptides

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A

Related Entries With Identical Sequence